Lymphomatoid granulomatosis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Kamal Akbar (talk | contribs) No edit summary |
Kamal Akbar (talk | contribs) No edit summary |
||
| (9 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Lymphomatoid granulomatosis}} | {{Lymphomatoid granulomatosis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{kakbar}} | ||
==Overview== | ==Overview== | ||
Lymphomatoid granulomatosis is a rare disease with which has prevalence that is not known. Its incidence is higher in males (male : female ratio 2 : 1), and it tends to occur between the 5th to 6th decade of life. It is more frequent in Europe than in Asia.<ref name="pmid24981698">{{cite journal| author=Sýkorová A, Campr V, Kašparová P, Kočová E, Belada D, Trněný M et al.| title=[Lymphomatoid granulomatosis - the past and present]. | journal=Vnitr Lek | year= 2014 | volume= 60 | issue= 3 | pages= 225-38 | pmid=24981698 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24981698 }} </ref> | [[Lymphomatoid granulomatosis]] is a rare disease with which has prevalence that is not known. Its incidence is higher in males (male : female ratio 2 : 1), and it tends to occur between the 5th to 6th decade of life. It is more frequent in Europe than in Asia.<ref name="pmid24981698">{{cite journal| author=Sýkorová A, Campr V, Kašparová P, Kočová E, Belada D, Trněný M et al.| title=[Lymphomatoid granulomatosis - the past and present]. | journal=Vnitr Lek | year= 2014 | volume= 60 | issue= 3 | pages= 225-38 | pmid=24981698 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24981698 }} </ref> | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
* | *There is no documentation on the incidence of this disease. | ||
===Prevalence=== | ===Prevalence=== | ||
* | *Prevalence of the diseases is unknown. | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
* | *Some sources that the mortality rate can be at 50%, but the prognosis is still variable.<ref name="pmid21107080">{{cite journal| author=Katzenstein AL, Doxtader E, Narendra S| title=Lymphomatoid granulomatosis: insights gained over 4 decades. | journal=Am J Surg Pathol | year= 2010 | volume= 34 | issue= 12 | pages= e35-48 | pmid=21107080 | doi=10.1097/PAS.0b013e3181fd8781 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21107080 }} </ref> | ||
===Age=== | ===Age=== | ||
* | *Usually occurs in the 5th to 6th decade of life, but there have been cases where the condition has occurred in adolescence.<ref name="pmid24981698">{{cite journal| author=Sýkorová A, Campr V, Kašparová P, Kočová E, Belada D, Trněný M et al.| title=[Lymphomatoid granulomatosis - the past and present]. | journal=Vnitr Lek | year= 2014 | volume= 60 | issue= 3 | pages= 225-38 | pmid=24981698 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24981698 }} </ref> | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to | *There is no racial predilection to Lymphomatoid granulomatosis. | ||
===Gender=== | ===Gender=== | ||
* | *Males are more commonly affected by Lymphmatoid granulomatosis than females. The male to female ratio is approximately (male : female ratio 2 : 1). | ||
===Region=== | ===Region=== | ||
*The majority of | *The majority of Lymphomtoid graulomatosis cases are reported in Europe and Asia. | ||
==References== | ==References== | ||
Latest revision as of 21:09, 18 December 2018
|
Lymphomatoid granulomatosis Microchapters |
|
Differentiating Lymphomatoid granulomatosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphomatoid granulomatosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Lymphomatoid granulomatosis epidemiology and demographics |
|
FDA on Lymphomatoid granulomatosis epidemiology and demographics |
|
CDC on Lymphomatoid granulomatosis epidemiology and demographics |
|
Lymphomatoid granulomatosis epidemiology and demographics in the news |
|
Blogs on Lymphomatoid granulomatosis epidemiology and demographics |
|
Directions to Hospitals Treating Lymphomatoid granulomatosis |
|
Risk calculators and risk factors for Lymphomatoid granulomatosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kamal Akbar, M.D.[2]
Overview
Lymphomatoid granulomatosis is a rare disease with which has prevalence that is not known. Its incidence is higher in males (male : female ratio 2 : 1), and it tends to occur between the 5th to 6th decade of life. It is more frequent in Europe than in Asia.[1]
Epidemiology and Demographics
Incidence
- There is no documentation on the incidence of this disease.
Prevalence
- Prevalence of the diseases is unknown.
Case-fatality rate/Mortality rate
- Some sources that the mortality rate can be at 50%, but the prognosis is still variable.[2]
Age
- Usually occurs in the 5th to 6th decade of life, but there have been cases where the condition has occurred in adolescence.[1]
Race
- There is no racial predilection to Lymphomatoid granulomatosis.
Gender
- Males are more commonly affected by Lymphmatoid granulomatosis than females. The male to female ratio is approximately (male : female ratio 2 : 1).
Region
- The majority of Lymphomtoid graulomatosis cases are reported in Europe and Asia.
References
- ↑ 1.0 1.1 Sýkorová A, Campr V, Kašparová P, Kočová E, Belada D, Trněný M; et al. (2014). "[Lymphomatoid granulomatosis - the past and present]". Vnitr Lek. 60 (3): 225–38. PMID 24981698.
- ↑ Katzenstein AL, Doxtader E, Narendra S (2010). "Lymphomatoid granulomatosis: insights gained over 4 decades". Am J Surg Pathol. 34 (12): e35–48. doi:10.1097/PAS.0b013e3181fd8781. PMID 21107080.